Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial

Kasper Iversen; Annette Schophuus Jensen; Tim V Jensen; Niels G Vejlstrup; Lars Søndergaard

doi:10.1093/eurheartj/ehq011

Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial

Afdeling for Børn og Unge JMC

175 Citationer (Scopus)

Abstract

To evaluate the efficacy of combining the dual endothelin receptor antagonist, bosentan, and the phosfodiesterase-5-inhibitor, sildenafil, in patients with Eisenmenger syndrome.

Originalsprog	Engelsk
Tidsskrift	European Heart Journal
Vol/bind	31
Udgave nummer	9
Sider (fra-til)	1124-31
Antal sider	8
ISSN	0195-668X
DOI	https://doi.org/10.1093/eurheartj/ehq011
Status	Udgivet - 1 maj 2010

Adgang til dokumentet

10.1093/eurheartj/ehq011

Citationsformater

@article{6aef6d8507d04e84af02f3045faa7184,

title = "Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial",

abstract = "To evaluate the efficacy of combining the dual endothelin receptor antagonist, bosentan, and the phosfodiesterase-5-inhibitor, sildenafil, in patients with Eisenmenger syndrome.",

author = "Kasper Iversen and Jensen, \{Annette Schophuus\} and Jensen, \{Tim V\} and Vejlstrup, \{Niels G\} and Lars S{\o}ndergaard",

year = "2010",

month = may,

day = "1",

doi = "10.1093/eurheartj/ehq011",

language = "English",

volume = "31",

pages = "1124--31",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial

AU - Iversen, Kasper

AU - Jensen, Annette Schophuus

AU - Jensen, Tim V

AU - Vejlstrup, Niels G

AU - Søndergaard, Lars

PY - 2010/5/1

Y1 - 2010/5/1

N2 - To evaluate the efficacy of combining the dual endothelin receptor antagonist, bosentan, and the phosfodiesterase-5-inhibitor, sildenafil, in patients with Eisenmenger syndrome.

AB - To evaluate the efficacy of combining the dual endothelin receptor antagonist, bosentan, and the phosfodiesterase-5-inhibitor, sildenafil, in patients with Eisenmenger syndrome.

U2 - 10.1093/eurheartj/ehq011

DO - 10.1093/eurheartj/ehq011

M3 - Journal article

C2 - 20202971

SN - 0195-668X

VL - 31

SP - 1124

EP - 1131

JO - European Heart Journal

JF - European Heart Journal

IS - 9

ER -

Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater